ASD closure IN ASIA: techniques, complications and challenging cases

Thursday, September 17, 2026, 13:00 CEST / 7PM Beijing time

Moderators:

Edward Danson, University of Wollongong, Wollongong, Australia
Liu Kun, Huazhong University of Science and Technology, Wuhan, China

PROGRAM

Deficient margins in ASD – how to avoid procedure failure  >>  Fu Yun-Ching, Taichung Veterans General Hospital, Taichung, Taiwan

How to predict and deal with complications of ASD closure  >>  Ronnie Cheuk Bong Ho, Queen Elizabeth Hospital, Hong Kong

Challenging case treatment – any difference in pediatric vs adult  >>  Gwang-Jun Choi, Samsung Medical Center, Seoul, Republic of Korea

Iatrogenic ASD – do we expect more and when should we close them?  >>  Ata Doost, Macquarie University Hospital, Sydney, Australia

Are all Cobras bad?  >>  Tin Do Nguyen, Children's hospital 1, Ho Chi Minh, Vietnam

How to navigate across an ASD occluder for left atrial procedures  >>  Hidehiko Hara, Toho University Ohashi Medical Center, Tokyo, Japan

 

WATCH ON-DEMAND

 

Sponsored by:

 

 

Accredited for 1 EBAC credit

This program is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) for 2 hours of effective education time. EBAC® holds an agreement on mutual recognition of substantive equivalency with the US Accreditation Council for CME (ACCME) and the Royal College of Physicians and Surgeons of Canada, respectively. Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) and the American Medical Association, physicians may convert EBAC® External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC® credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™. EBAC® is a member of the International Academy for CPD Accreditation (IACPDA) and a partner member of the International Association of Medical Regulatory Authorities (IAMRA).